Emergent Biosolutions, Inc. (EBS) Financial Statements (2024 and earlier)

Company Profile

Business Address 400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG, MD 20879
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments642,600576,100621,300167,800112,200178,292
Cash and cash equivalents642,600576,100621,300167,800112,200178,292
Restricted cash and investments  2002002002001,043
Receivables159,200274,700230,900275,300271,100146,085
Inventory, net of allowances, customer advances and progress billings350,700350,800307,000222,500205,800142,812
Inventory350,700350,800307,000222,500205,800142,812
Contract with customer, asset, after allowance for credit loss  21,500   
Deferred costs     1,200 
Other undisclosed current assets57,90048,80036,50020,40030,30017,157
Total current assets:1,210,4001,272,1001,195,900686,200620,800485,389
Noncurrent Assets
Property, plant and equipment817,600800,100644,100542,300510,200407,210
Intangible assets, net (including goodwill)947,000829,500929,800979,5001,021,300168,727
Goodwill 218,200224,900266,700266,600259,70049,130
Intangible assets, net (excluding goodwill)728,800604,600663,100712,900761,600119,597
Other noncurrent assets191,30057,300113,40076,90013,7006,046
Other undisclosed noncurrent assets    42,40063,4002,834
Total noncurrent assets:1,955,9001,686,9001,687,3001,641,1001,608,600584,817
TOTAL ASSETS:3,166,3002,959,0002,883,2002,327,3002,229,4001,070,206
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities138,400269,300267,600196,700174,10084,464
Taxes payable   4,500 
Employee-related liabilities88,70084,60062,40058,20037,882
Accounts payable103,500128,900136,10094,80080,70041,751
Accrued liabilities34,90051,70046,90039,50030,7004,831
Deferred revenue26,400   
Debt957,300  12,90010,100 
Business combination, contingent consideration, liability3,400     
Deferred revenue and credits13,232
Contract with customer, liability10,600
Other liabilities45,90072,90083,1003,500  
Other undisclosed current liabilities57,50031,60033,8003,2005,6002,372
Total current liabilities:1,228,900373,800384,500216,300200,400100,068
Noncurrent Liabilities
Long-term debt and lease obligation448,500809,400841,000798,400784,50013,457
Long-term debt, excluding current maturities448,500809,400841,000798,400784,50013,457
Liabilities, other than long-term debt101,200156,800210,700134,200179,20034,434
Deferred revenue and credits17,259
Accounts payable and accrued liabilities     11,20012,500
Deferred revenue  4,70055,500 
Contract with customer, liability85,60062,500
Deferred tax liabilities, net67,500 
Deferred income tax liabilities59,70094,90053,200 
Other liabilities41,50052,70067,80048,60038,0004,675
Business combination, contingent consideration, liability  4,50034,200   
Other undisclosed noncurrent liabilities    89,90054,4009,902
Total noncurrent liabilities:549,700966,2001,051,7001,022,5001,018,10057,793
Total liabilities:1,778,6001,340,0001,436,2001,238,8001,218,500157,861
Equity
Equity, attributable to parent1,387,7001,619,0001,447,0001,088,5001,010,900912,345
Common stock10010010010010050
Treasury stock, value(227,700)(152,200)(39,600)(39,600)(39,600)(39,497)
Additional paid in capital873,500829,400784,900716,100688,600618,416
Accumulated other comprehensive income (loss)3,100(16,100)(25,300)(9,900)(5,500)(3,698)
Retained earnings738,700957,800726,900421,800367,300337,074
Total equity:1,387,7001,619,0001,447,0001,088,5001,010,900912,345
TOTAL LIABILITIES AND EQUITY:3,166,3002,959,0002,883,2002,327,3002,229,4001,070,206

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues1,117,5001,792,7001,555,4001,106,000782,400560,873
Revenue, net560,873
Cost of revenue
(Cost of Goods and Services Sold)
(693,100) (524,000)(433,500)(322,300)(195,707)
Other undisclosed gross profit(41,400)     
Gross profit:383,0001,792,7001,031,400672,500460,100365,166
Operating expenses(1,287,500)(1,440,100)(1,121,600)(991,900) (240,881)
Other undisclosed operating income (loss)734,500 524,000433,500(370,300) 
Operating income (loss):(170,000)352,600433,800114,10089,800124,285
Nonoperating expense(49,000)(38,200)(26,600)(36,700)(8,300)(5,652)
Investment income, nonoperating      1,753
Other nonoperating income (expense)(11,700)(3,700)4,7001,7001,600(815)
Interest and debt expense(37,300)(34,500)(31,300)(38,400)(9,900)(6,590)
Other undisclosed income from continuing operations before equity method investments, income taxes   31,30038,4009,9006,590
Income (loss) from continuing operations before equity method investments, income taxes:(256,300)279,900407,20077,40081,500118,633
Other undisclosed income from continuing operations before income taxes37,30034,500    
Income (loss) from continuing operations before income taxes:(219,000)314,400407,20077,40081,500118,633
Income tax expense (benefit)7,400(83,500)(102,100)(22,900)(18,800)(36,039)
Income (loss) from continuing operations:(211,600)230,900305,10054,50062,70082,594
Income before gain (loss) on sale of properties:230,900305,10054,50062,70082,594
Net income (loss) available to common stockholders, diluted:(211,600)230,900305,10054,50062,70082,594

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(211,600)230,900305,10054,50062,70082,594
Other comprehensive loss    (400)(1,800) 
Other undisclosed comprehensive income      633
Comprehensive income (loss):(211,600)230,900305,10054,10060,90083,227
Other undisclosed comprehensive income (loss), net of tax, attributable to parent19,2009,200(15,400)(4,000)  
Comprehensive income (loss), net of tax, attributable to parent:(192,400)240,100289,70050,10060,90083,227

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: